Skip to content

Pre-Exercise Mood and Physiological Responses to Maximal Effort in Elite Rowers

Acute Psychoneuroendocrine Responses to Maximal Exertion Following High-Load Training in Elite Rowers: A Sex-Based Comparative Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07243613
Acronym
6000MFPOMS2024
Enrollment
28
Registered
2025-11-24
Start date
2024-03-15
Completion date
2025-06-30
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Adult Subjects

Keywords

Exercise-induced Fatigue, Elithe Athletes, Neurtransmitters, Mood State

Brief summary

This study examined how the body and mood respond to intense physical effort in elite male and female rowers. Athletes completed a maximal rowing test after one week of hard training. Researchers collected blood samples before and after exercise to measure stress hormones and brain-related chemicals. They also used a short questionnaire to assess how the athletes felt emotionally before the test. The goal of the study is to better understand how physical and mental fatigue develop in well-trained athletes, and whether men and women respond differently.

Detailed description

This observational cohort study was designed to characterize acute physiological and psychological responses to maximal exertion following a high-load training period in elite male and female rowers. The main aim was to investigate how accumulated training fatigue affects hormonal and neurochemical responses to intense effort, and whether these responses differ by sex. Participants were national-level athletes undergoing a standardized 7-day training camp, during which they completed identical high-intensity training sessions. On day 8, all participants performed a 2000-m maximal rowing ergometer test under controlled conditions. Blood samples were collected at three time points: before exercise (PRE), immediately post-exercise (POST), and 1 hour post-exercise (1H). Biomarkers analyzed in serum included cortisol, total testosterone, serotonin (5-HT), dopamine (DA), gamma-aminobutyric acid (GABA), and tryptophan. The testosterone-to-cortisol (T/C) ratio was used as an index of anabolic-catabolic balance, while the 5-HT/DA ratio was examined as a neurochemical indicator of central fatigue. In parallel, mood state was assessed once prior to the exertion test using the standardized Profile of Mood States (POMS) questionnaire. This provided insight into psychological readiness and emotional state entering maximal effort. A total of 28 athletes (12 females, 16 males) completed the full protocol. There were no missing data. The study did not involve any interventions, randomization, or masking. Statistical analyses included repeated-measures ANOVA for time and group effects, and calculation of within-group effect sizes (Cohen's d). Although no biospecimens were retained beyond initial analysis, serum samples were processed and stored short-term according to laboratory standards. The study followed ethical approval procedures and informed consent was obtained from all participants. No external monitoring, third-party auditing, or source data verification was implemented, as this was a single-site, non-interventional academic study. The data collected provide a multidimensional profile of physiological and mood-related responses to intense physical effort under conditions of cumulative fatigue. These findings may inform future monitoring strategies in high-performance sport and support individualized recovery planning.

Interventions

OTHERMaximal Rowing Test

Participants completed a 2000-meter maximal rowing ergometer test on day 8 following a standardized 7-day high-load training period. The test served as the physiological and psychological stressor used to assess acute fatigue responses.

Sponsors

Poznan University of Physical Education
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

Aged 19-25 years National-level competitive rower Minimum 5 years of structured rowing training Currently in full training and competition season Completed 7-day standardized high-load training program Provided written informed consent

Exclusion criteria

Use of medications or supplements affecting hormonal or neurochemical markers Known endocrine, neurological, or psychiatric disorders Injury or illness interfering with training or testing Incomplete participation in the training camp or testing protocol

Design outcomes

Primary

MeasureTime frameDescription
Serum Tryptophan concentrationBefore exercise, immediately after, and 1 hour after recoveryTryptophan concentration will be measured in serum using an immunoassay. Units: µg/dL
Serum Gamma-aminobutyric acid (GABA) concentrationBefore exercise, immediately after, and 1 hour after recoveryGABA concentration will be measured in serum using an immunoassay. Units: µg/dL
Profile of Mood StatesBefore exerciseSelf-reported mood assessed using the Profile of Mood States (POMS); total and subscale scores.
Serum Testosterone concentrationBefore exercise, immediately after, and 1 hour after recoveryTestosterone concentration will be measured in serum using immunoassay. Units: ng/mL.
Serum Cortisol concentrationBefore exercise, immediately after, and 1 hour after recoveryCortisol concentration will be measured in serum using an immunoassay. Units: ng/mL
Serum Serotonin concentrationBefore exercise, immediately after, and 1 hour after recoverySerotonin concentration will be measured in serum using an immunoassay. Units: ng/mL

Secondary

MeasureTime frameDescription
S:D ratioBefore exercise, immediately after, and 1 hour after recoveryRatio of serum serotonin to dopamine to assess neurochemical fatigue profile.
T:C ratioBefore exercise, immediately after, and 1 hour after recoveryRatio of serum testosterone to cortisol as an index of anabolic-catabolic balance

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 14, 2026